Close Menu

NEW YORK – Danaher announced Tuesday it has priced an offering of $1 billion of 2.6 percent senior notes due in 2050 at an offering price of 98.97 percent of the principal amount.

The company expects net proceeds to be $980 million after underwriting discounts and offering expenses. Danaher said it will use the money for general corporate purposes, including refinancing of outstanding debts, working capital, and capital expenditures.

The offering is expected to close Oct. 6, subject to customary closing conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.